Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof

US Patent 9555101 · Granted Jan 31, 2017

Estimated economic value: $47,481,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant virus capable of stably expressing target proteins2024
Reassortant BTV and AHSV vaccines2020
Methods for freeze-drying and rehydrating biologics2020
Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2020
Antibiotic-free plasmid2019
FMDV and E2 fusion proteins and uses thereof2019
Hendra virus recombinant compositions and uses thereof2019
Hendra virus recombinant compositions and uses thereof2019
High resolution melt genotyping of IBV, CSFV and NDV2018
Canine parvovirus (CPV) virus-like particle (VLP) vaccines and uses thereof2018
Recombinant CDV compositions and uses thereof2018
Recombinant CDV compositions and uses thereof2018